Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck's weekly diabetes drug stacks up to blockbuster Januvia in Phase III
Merck's weekly diabetes drug stacks up to blockbuster Januvia in Phase III
Merck's weekly diabetes drug stacks up to blockbuster Januvia in Phase III
Submitted by
admin
on September 18, 2014 - 9:24am
Source:
Fierce Biotech
News Tags:
Merck
diabetes
Januvia
omarigliptin
MK-3102
Headline:
Merck's weekly diabetes drug stacks up to blockbuster Januvia in Phase III
Do Not Allow Advertisers to Use My Personal information
